Akcea Therapeutics, Inc.

Bank of New York Mellon Corp

Report date

9/30/2020

Quarter

2020 Q3

Filed

11/12/2020

Shares

70,588

Value ($000)

1,281

Weight

0.0%

2019 Q4 - 2020 Q3 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q3	11/12/2020	1,281	0.0%	70,588	9/30/2020
2020 Q2	8/12/2020	958	0.0%	69,969	6/30/2020
2020 Q1	5/6/2020	836	0.0%	58,445	3/31/2020
2019 Q4	2/14/2020	980	0.0%	57,838	12/31/2019